Lexaria Bioscience (LEXX) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart

Lexaria Bioscience Revenue Highlights

Latest Revenue (Y)

$226.21K

Latest Revenue (Q)

$84.00K

Main Segment (Y)

License

Main Geography (Y)

License

Lexaria Bioscience Revenue by Period

Lexaria Bioscience Revenue by Year

Date	Revenue	Change
2023-08-31	$226.21K	-11.43%
2022-08-31	$255.40K	-64.66%
2021-08-31	$722.74K	87.95%
2020-08-31	$384.54K	72.74%
2019-08-31	$222.61K	-48.62%
2018-08-31	$433.29K	580.85%
2017-08-31	$63.64K	56.29%
2016-08-31	$40.72K	176.96%
2015-08-31	$14.70K	-98.66%
2014-08-31	$1.10M	-19.17%
2012-10-31	$1.36M	19.76%
2011-10-31	$1.13M	212.79%
2010-10-31	$362.47K	-14.10%
2009-10-31	$421.95K	-53.16%
2008-10-31	$900.79K	255.83%
2007-10-31	$253.15K	1146.60%
2006-10-31	$20.31K	100.00%
2005-10-31	-	-

Lexaria Bioscience generated $226.21K in revenue during NA 2023, up -11.43% compared to the previous quarter, and up 52.21% compared to the same period a year ago.

Lexaria Bioscience Revenue by Quarter

Date	Revenue	Change
2024-05-31	$84.00K	-42.07%
2024-02-29	$145.00K	-4.15%
2023-11-30	$151.28K	-4506.58%
2023-08-31	$-3.43K	-103.69%
2023-05-31	$93.15K	166.03%
2023-02-28	$35.02K	-65.49%
2022-11-30	$101.48K	-8.70%
2022-08-31	$111.15K	11.47%
2022-05-31	$99.72K	225.34%
2022-02-28	$30.65K	120.82%
2021-11-30	$13.88K	-55.26%
2021-08-31	$31.02K	-84.80%
2021-05-31	$204.06K	6.28%
2021-02-28	$192.01K	-35.06%
2020-11-30	$295.66K	121.07%
2020-08-31	$133.74K	64.25%
2020-05-31	$81.42K	-24.12%
2020-02-29	$107.30K	72.83%
2019-11-30	$62.08K	-50.38%
2019-08-31	$125.12K	108.78%
2019-05-31	$59.93K	290.46%
2019-02-28	$15.35K	-30.89%
2018-11-30	$22.21K	-76.95%
2018-08-31	$96.35K	-31.34%
2018-05-31	$140.34K	-18.39%
2018-02-28	$171.96K	598.02%
2017-11-30	$24.64K	96.15%
2017-08-31	$12.56K	-57.07%
2017-05-31	$29.25K	132.13%
2017-02-28	$12.60K	36.61%
2016-11-30	$9.22K	7.74%
2016-08-31	$8.56K	37.76%
2016-05-31	$6.21K	-58.99%
2016-02-29	$15.15K	227.16%
2015-08-31	$4.63K	-35.55%
2015-05-31	$7.19K	149.29%
2015-02-28	$2.88K	100.00%
2014-11-30	-	-100.00%
2014-07-31	$135.86K	-19.05%
2014-04-30	$167.84K	4.83%
2014-01-31	$160.10K	-33.59%
2013-10-31	$241.09K	-4.13%
2013-07-31	$251.48K	-0.75%
2013-04-30	$253.39K	-27.91%
2013-01-31	$351.49K	-25.06%
2012-10-31	$469.04K	-5.15%
2012-07-31	$494.48K	241.35%
2012-04-30	$144.86K	-41.91%
2012-01-31	$249.38K	95.29%
2011-10-31	$127.70K	-64.49%
2011-07-31	$359.62K	13.70%
2011-04-30	$316.28K	-4.20%
2011-01-31	$330.16K	169.60%
2010-07-31	$122.46K	203.67%
2010-04-30	$40.33K	-57.99%
2009-10-31	$95.99K	-25.90%
2009-07-31	$129.54K	92.87%
2009-04-30	$67.17K	-48.04%
2009-01-31	$129.26K	32.58%
2008-10-31	$97.50K	-58.08%
2008-07-31	$232.56K	7.48%
2008-04-30	$216.39K	-38.93%
2008-01-31	$354.34K	239.34%
2007-10-31	$104.42K	18.67%
2007-07-31	$87.99K	122.11%
2007-04-30	$39.61K	100.00%
2006-10-31	-	100.00%
2006-07-31	-	100.00%
2006-04-30	-	-

Lexaria Bioscience generated $84.00K in revenue during Q3 2024, up -42.07% compared to the previous quarter, and up 239.90% compared to the same period a year ago.

Lexaria Bioscience Revenue Breakdown

Lexaria Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Aug 20	Aug 19	Aug 18
License	$232.91K	$198.00K	$415.18K
Product	$121.91K	$24.28K	$16.97K
Freight revenuet	$641.00	$328.00	-
Cargo and Freight	-	-	$1.14K

Lexaria Bioscience's latest annual revenue breakdown by segment (product or service), as of Aug 20: License (65.52%), Product (34.30%), and Freight revenuet (0.18%).

Quarterly Revenue by Product

Product/Service	May 24	Feb 24	May 21	Feb 21	Nov 20	Aug 20	May 20	Feb 20	Nov 19	Aug 19	May 19	Feb 19	Nov 18	May 18
IP Licensing	$373.99K	$289.99K	-	-	-	-	-	-	-	-	-	-	-	-
Other	$900.00	$900.00	-	-	-	-	-	-	-	-	-	-	-	-
Freight Revenue	-	-	-	$18.00	$82.00	-	-	-	-	-	-	-	-	-
Interest Revenue	-	-	$4.58K	-	-	-	-	-	-	-	-	-	-	-
License Revenue	-	-	$70.63K	-	-	-	-	-	-	-	-	-	-	-
Product Sales	-	-	$128.84K	-	-	-	-	-	-	-	-	-	-	-
License	-	-	-	$125.26K	$130.58K	$102.40K	$60.76K	$18.00K	$51.75K	$108.00K	$58.00K	$12.10K	$19.90K	-
Product	-	-	-	$66.73K	$164.99K	$31.28K	$20.52K	$89.18K	$10.02K	$17.00K	$1.85K	$3.18K	$2.26K	-
Freight revenuet	-	-	-	-	-	$55.00	$146.00	$123.00	$317.00	$123.00	$83.00	$122.00	-	-
Cargo and Freight	-	-	-	-	-	-	-	-	-	-	-	-	$50.00	-
Intellectual Property Licensing	-	-	-	-	-	-	-	-	-	-	-	-	-	$137.60K
Consumer Products	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.74K

Lexaria Bioscience's latest quarterly revenue breakdown by segment (product or service), as of May 24: IP Licensing (99.76%), and Other (0.24%).

Lexaria Bioscience Revenue Breakdown by Country

Annual Revenue by Country

Country	Aug 20	Aug 19	Aug 18
Freight revenuet	$641.00	$328.00	-
Product	$121.91K	$24.28K	$16.97K
License	$232.91K	$198.00K	$415.18K
Cargo and Freight	-	-	$1.14K

Lexaria Bioscience's latest annual revenue breakdown by geography, as of Aug 20: License (65.52%), Product (34.30%), and Freight revenuet (0.18%).

Quarterly Revenue by Country

Country	May 21	Feb 21	Nov 20	Aug 20	May 20	Feb 20	Nov 19	Aug 19	May 19	Feb 19	Nov 18	May 18
Interest Revenue	$4.58K	-	-	-	-	-	-	-	-	-	-	-
Freight Revenue	-	$18.00	$82.00	-	-	-	-	-	-	-	-	-
Product Sales	$128.84K	-	-	-	-	-	-	-	-	-	-	-
License Revenue	$70.63K	-	-	-	-	-	-	-	-	-	-	-
Product	-	$66.73K	$164.99K	$31.28K	$20.52K	$89.18K	$10.02K	$17.00K	$1.85K	$3.18K	$2.26K	-
License	-	$125.26K	$130.58K	$102.40K	$60.76K	$18.00K	$51.75K	$108.00K	$58.00K	$12.10K	$19.90K	-
Freight revenuet	-	-	-	$55.00	$146.00	$123.00	$317.00	$123.00	$83.00	$122.00	-	-
Cargo and Freight	-	-	-	-	-	-	-	-	-	-	$50.00	-
Consumer Products	-	-	-	-	-	-	-	-	-	-	-	$2.74K
Intellectual Property Licensing	-	-	-	-	-	-	-	-	-	-	-	$137.60K

Lexaria Bioscience's latest quarterly revenue breakdown by geography, as of May 21: Product Sales (63.14%), License Revenue (34.61%), and Interest Revenue (2.25%).

Lexaria Bioscience Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BDRX	Biodexa Pharmaceuticals	$381.00K	$41.50K
LEXX	Lexaria Bioscience	$226.21K	$84.00K
SONN	Sonnet BioTherapeutics	$147.81K	-
CNSP	CNS Pharmaceuticals	-	-
ZURA	Zura Bio	-	-
REVB	Revelation Biosciences	-	-
ICU	SeaStar Medical	-	-
PHIO	Phio Pharmaceuticals	-	-
ZVSA	ZyVersa Therapeutics	-	-
IMMX	Immix Biopharma	-	-
ONCR	Oncorus	-	-
RNAZ	TransCode Therapeutics	-	-
VIRI	Virios Therapeutics	-	-
EFTR	eFFECTOR Therapeutics	-	-

LEXX Revenue FAQ

What is Lexaria Bioscience’s yearly revenue?

Lexaria Bioscience's yearly revenue for 2023 was $226.21K, representing a decrease of -11.43% compared to 2022. The company's yearly revenue for 2022 was $255.4K, representing a decrease of -64.66% compared to 2021. LEXX's yearly revenue for 2021 was $722.74K, representing an increase of 87.95% compared to 2020.

What is Lexaria Bioscience’s quarterly revenue?

Lexaria Bioscience's quarterly revenue for Q3 2024 was $84K, a -42.07% decrease from the previous quarter (Q2 2024), and a -9.82% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $145K, a -4.15% decrease from the previous quarter (Q1 2024), and a 314.11% increase year-over-year (Q2 2023). LEXX's quarterly revenue for Q1 2024 was $151.28K, a -4506.58% decrease from the previous quarter (Q4 2023), and a 49.08% increase year-over-year (Q1 2023).

What is Lexaria Bioscience’s revenue growth rate?

Lexaria Bioscience's revenue growth rate for the last 3 years (2021-2023) was -68.70%, and for the last 5 years (2019-2023) was 1.62%.

What are Lexaria Bioscience’s revenue streams?

Lexaria Bioscience's revenue streams in g 20 are License, Product, and Freight revenuet. License generated $232.91K in revenue, accounting 65.52% of the company's total revenue, up 17.63% year-over-year. Product generated $121.91K in revenue, accounting 34.30% of the company's total revenue, up 402.04% year-over-year. Freight revenuet generated $641 in revenue, accounting 0.18% of the company's total revenue, up 95.43% year-over-year.

What is Lexaria Bioscience’s main source of revenue?

For the fiscal year ending Aug 20, the largest source of revenue of Lexaria Bioscience was License. This segment made a revenue of $232.91K, representing 65.52% of the company's total revenue.